These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18674490)

  • 1. [Pharmacogenetics in oncology].
    Morán González D; Jiménez Cabrera S; Domínguez-Gil Hurlé A
    Med Clin (Barc); 2008 Jul; 131(5):184-95. PubMed ID: 18674490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics in oncology: a promising field.
    Houtsma D; Guchelaar HJ; Gelderblom H
    Curr Pharm Des; 2010; 16(2):155-63. PubMed ID: 20205661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of drug-metabolising enzymes in clinical responses to chemotherapy.
    Scripture CD; Figg WD; Sparreboom A
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):17-25. PubMed ID: 16863465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response.
    Donnelly JG
    Ther Drug Monit; 2004 Apr; 26(2):231-5. PubMed ID: 15228171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
    Deeken JF; Figg WD; Bates SE; Sparreboom A
    Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Pharmacogenetic Markers of Irinotecan Toxicity.
    Hahn RZ; Antunes MV; Verza SG; Perassolo MS; Suyenaga ES; Schwartsmann G; Linden R
    Curr Med Chem; 2019; 26(12):2085-2107. PubMed ID: 29932028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized drug therapy.
    Daly AK
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM; Meijerman I; Beijnen JH; Schellens JH
    Clin Pharmacokinet; 2006; 45(3):253-85. PubMed ID: 16509759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic progress in individualized dosing of key drugs for cancer patients.
    Walko CM; McLeod H
    Nat Clin Pract Oncol; 2009 Mar; 6(3):153-62. PubMed ID: 19174777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics and cancer chemotherapy.
    Iyer L; Ratain MJ
    Eur J Cancer; 1998 Sep; 34(10):1493-9. PubMed ID: 9893619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR; McLeod HL
    J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic applications in oncology.
    Walko CM; Ikediobi O
    J Pharm Pract; 2012 Aug; 25(4):439-46. PubMed ID: 22907843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
    Danesi R; De Braud F; Fogli S; Di Paolo A; Del Tacca M
    Trends Pharmacol Sci; 2001 Aug; 22(8):420-6. PubMed ID: 11479005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.